SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-24-061600
Filing Date
2024-07-16
Accepted
2024-07-16 10:31:43
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS ea0209406-424b3_unicycive.htm 424B3 357332
2 GRAPHIC image_001.jpg GRAPHIC 11505
3 GRAPHIC image_002.jpg GRAPHIC 45523
  Complete submission text file 0001213900-24-061600.txt   437172
Mailing Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022
Business Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022 650-384-0642
Unicycive Therapeutics, Inc. (Filer) CIK: 0001766140 (see all company filings)

IRS No.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-280703 | Film No.: 241118804
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)